Cefuroxime-d3

CAT:
804-HY-B1256S
Size:
1 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Cefuroxime-d3 - image 1

Cefuroxime-d3

  • Description :

    Cefuroxime-d3 is deuterium labeled Cefuroxime (sodium) . Cefuroxime sodium is an orally active second-generation cephalosporin antibiotic with increased stability to β-lactamase. Cefuroxime sodium has a broad spectrum activity against Gram-positive and Gram-negative bacteria[1].
  • UNSPSC :

    12352005
  • Hazard Statement :

    H302-H315-H319-H335
  • Target :

    Antibiotic; Bacterial; Isotope-Labeled Compounds
  • Type :

    Isotope-Labeled Compounds
  • Related Pathways :

    Anti-infection; Others
  • Applications :

    COVID-19-immunoregulation
  • Field of Research :

    Infection
  • Solubility :

    10 mM in DMSO
  • Smiles :

    OC(C1=C(COC(N)=O)CS[C@@]([C@@H]2NC(/C(C3=CC=CO3)=N\OC([2H])([2H])[2H])=O)([H])N1C2=O)=O
  • Molecular Formula :

    C16H13D3N4O8S
  • Molecular Weight :

    427.40
  • Precautions :

    P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
  • References & Citations :

    [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Callaghan, et al. Cefuroxime sodium, a New Cephalosporin Antibiotic: Activity in Vitro. Antimicrob Agents Chemother. 1976 Mar;9 (3) :511-9.|[3]D M Ryan, et al. Cefuroxime sodium, a New Cephalosporin Antibiotic: Activity in Vivo. Antimicrob Agents Chemother. 1976 Mar;9 (3) :520-5.
  • Shipping Conditions :

    Room temperature
  • Scientific Category :

    Isotope-Labeled Compounds
  • Clinical Information :

    No Development Reported
  • Isoform :

    β-lactam
  • CAS Number :

    [1803240-98-3]

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide